- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有1家主力机构披露2026-06-30报告期持股数据，持仓量总计5.41万股，占流通A股0.01%
- 波段诊断：
-
技术面诊股
诊断结果：4.1技术面打败了40%的股票
技术面评分前10的股票
近期的平均成本为8.45元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为8.45元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.45","date":1784793961,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.07.24","stock":"-3.38","trade":"-3.95","ind":"-2.47"},{"date":"2026.07.23","stock":"0.94","trade":"-0.26","ind":"0.44"},{"date":"2026.07.22","stock":"-1.28","trade":"-0.90","ind":"-1.42"},{"date":"2026.07.21","stock":"-2.05","trade":"-0.66","ind":"4.81"},{"date":"2026.07.20","stock":"-7.07","trade":"0.38","ind":"-0.71"},{"date":"2026.07.17","stock":"-9.98","trade":"-7.01","ind":"-5.40"},{"date":"2026.07.16","stock":"-4.01","trade":"0.36","ind":"-1.97"},{"date":"2026.07.15","stock":"6.10","trade":"2.67","ind":"-0.97"},{"date":"2026.07.14","stock":"1.18","trade":"2.74","ind":"2.77"},{"date":"2026.07.13","stock":"-2.30","trade":"-1.36","ind":"-3.48"},{"date":"2026.07.10","stock":"10.00","trade":"3.33","ind":"-2.29"},{"date":"2026.07.09","stock":"-1.25","trade":"0.10","ind":"3.07"},{"date":"2026.07.08","stock":"0.84","trade":"-1.54","ind":"-1.87"},{"date":"2026.07.07","stock":"-5.73","trade":"-4.28","ind":"-1.24"},{"date":"2026.07.06","stock":"-0.98","trade":"1.41","ind":"-1.16"},{"date":"2026.07.03","stock":"-4.22","trade":"1.88","ind":"0.64"},{"date":"2026.07.02","stock":"10.00","trade":"-0.24","ind":"-3.85"},{"date":"2026.07.01","stock":"2.54","trade":"4.33","ind":"-0.53"},{"date":"2026.06.30","stock":"3.84","trade":"-0.54","ind":"2.48"},{"date":"2026.06.29","stock":"10.02","trade":"7.43","ind":"0.19"},{"date":"2026.06.26","stock":"-2.24","trade":"-3.87","ind":"-3.44"}]
双成药业,深证成指,生物制品指数
压力支撑
该股压力位为8.44元，支撑位为8.21元。
[{"text":"\u538b\u529b\u4f4d","value":"8.44","date":1784822400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.21","date":1784822400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.8资金面打败了2%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月24日 20:30
| 机构今日流向(万元) | -2881.25 | 机构5日流向(万元) | -3356.94 |
| 机构10日流向(万元) | -2900.62 | 机构20日流向(万元) | 2491.41 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少20316.18万股，其中基金数没有增加，主力净减仓2家，请投资者中长期谨慎为宜。
截止2026-06-30，共1家主力机构（基金1家），持仓量总计5.41万股，占流通A股0.01%
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有5.41万股
从主力名单中消失：3家 ，原持有20321.59万股
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有5.41万股
从主力名单中消失：3家 ，原持有20321.59万股
消息面诊股
诊断结果：6.8消息面打败了75%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 多重政策红利释放 海南板块业绩多点开花
2026-07-24 - “喝酒吃药”行情重现，多个因素刺激消费股大涨！真正
2026-07-15 - 双成药业：预计2026年上半年净利润同比增长154
2026-07-14 - 涨停雷达：CRO+阿尔茨海默概念+多肽药+许可协议
2026-07-10 - 仿制药概念股午后震荡回暖 双成药业涨停
2026-07-02 - 涨停雷达：许可协议+紫杉醇+海南自贸区+扭亏 双成
2026-07-02 - 双成药业：根据相关规定如达到半年度业绩预告披露标准
2026-07-01 - 达成目标可获千万美元许可费 双成药业拟与合作方A公
2026-06-30 - 6月29日增减持汇总：通裕重工等6股披露增持情况，
2026-06-30 - 双成药业：部分董事、高管拟减持公司不超过0.10%
2026-06-29
消息列表
| 利好 | 业绩预告 | 预计扭亏 | 2026-07-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-27 |
| 利好 | 上市变动 | 公司摘帽 | 2026-05-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-09 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-27 |
| 一般消息 | 高管变动 | 不再担任 | 2026-01-08 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-06 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-07-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.8行业面打败了81%的股票
生物制品行业最新资金流向
近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2026.07.24","price":"-2.47","value":"-3.95"},{"date":"2026.07.23","price":"0.44","value":"-0.26"},{"date":"2026.07.22","price":"-1.42","value":"-0.90"},{"date":"2026.07.21","price":"4.81","value":"-0.66"},{"date":"2026.07.20","price":"-0.71","value":"0.38"},{"date":"2026.07.17","price":"-5.40","value":"-7.01"},{"date":"2026.07.16","price":"-1.97","value":"0.36"},{"date":"2026.07.15","price":"-0.97","value":"2.67"},{"date":"2026.07.14","price":"2.77","value":"2.74"},{"date":"2026.07.13","price":"-3.48","value":"-1.36"},{"date":"2026.07.10","price":"-2.29","value":"3.33"},{"date":"2026.07.09","price":"3.07","value":"0.10"},{"date":"2026.07.08","price":"-1.87","value":"-1.54"},{"date":"2026.07.07","price":"-1.24","value":"-4.28"},{"date":"2026.07.06","price":"-1.16","value":"1.41"},{"date":"2026.07.03","price":"0.64","value":"1.88"},{"date":"2026.07.02","price":"-3.85","value":"-0.24"},{"date":"2026.07.01","price":"-0.53","value":"4.33"},{"date":"2026.06.30","price":"2.48","value":"-0.54"},{"date":"2026.06.29","price":"0.19","value":"7.43"},{"date":"2026.06.26","price":"-3.44","value":"-3.87"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 艾迪药业 | 29.42% | -2.34% | 5.8分 |
| 2 | 君实生物 | 20.89% | 2.22% | 5.5分 |
| 3 | 迈威生物 | 20.41% | 0.29% | 5.4分 |
| 4 | 长春高新 | 20.08% | 4.04% | 5.8分 |
| 5 | 百普赛斯 | 19.44% | 8.00% | 6.2分 |
| 6 | 甘李药业 | 17.72% | -1.51% | 5.6分 |
| 8 | 康辰药业 | 13.64% | -7.72% | 5.6分 |
| 10 | 特宝生物 | 11.28% | 2.38% | 5.9分 |
| 12 | 诺唯赞 | 9.61% | 0.00% | 6.0分 |
| 14 | 智翔金泰 | 8.96% | -1.60% | 5.0分 |
| 16 | 康弘药业 | 7.53% | -4.81% | 5.3分 |
| 18 | 智飞生物 | 6.59% | -1.14% | 5.2分 |
| 20 | 博晖创新 | 6.46% | -5.52% | 5.3分 |
| 22 | 荣昌生物 | 5.32% | 2.58% | 5.6分 |
| 24 | 安科生物 | 4.93% | -3.79% | 5.4分 |
| 26 | 禾元生物 | 4.75% | -12.20% | 5.2分 |
| 28 | 西藏药业 | 4.55% | -2.82% | 5.1分 |
| 30 | 三生国健 | 2.99% | -3.11% | 5.6分 |
| 32 | 百克生物 | 2.50% | -5.56% | 5.3分 |
| 34 | 神州细胞 | 2.30% | -7.00% | 5.2分 |
| 36 | 博雅生物 | 1.62% | -7.92% | 5.2分 |
| 38 | 康希诺 | 0.94% | -2.42% | 4.8分 |
| 40 | *ST未名 | 0.63% | -11.29% | 4.7分 |
| 42 | 赛升药业 | 0.24% | -9.54% | 4.5分 |
| 44 | 康华生物 | -2.03% | -6.26% | 4.8分 |
| 46 | 金迪克 | -5.19% | -10.80% | 4.5分 |
| 48 | 卫光生物 | -6.09% | -10.18% | 4.8分 |
| 50 | 万泽股份 | -8.83% | 4.08% | 4.4分 |
| 52 | 东宝生物 | -14.39% | -10.14% | 5.3分 |
| 54 | 欧林生物 | -33.05% | -15.72% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 24/71 ， 34/71。
[{"date":"2026-03-31","value":"0.83","vol":"-6.01"},{"date":"2025-12-31","value":"4.73","vol":"-12.99"},{"date":"2025-09-30","value":"-0.64","vol":"-10.09"},{"date":"2025-06-30","value":"-4.81","vol":"-0.66"},{"date":"2025-03-31","value":"-2.59","vol":"-0.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.83 | 4.73 | -0.64 | -4.81 | -2.59 |
| 行业(%) | -6.01 | -12.99 | -10.09 | -0.66 | -0.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"62.35","vol":"61.43"},{"date":"2025-12-31","value":"54.75","vol":"66.53"},{"date":"2025-09-30","value":"56.71","vol":"67.71"},{"date":"2025-06-30","value":"46.72","vol":"66.67"},{"date":"2025-03-31","value":"49.57","vol":"38.38"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
62.35 | 54.75 | 56.71 | 46.72 | 49.57 |
| 行业(%) | 61.43 | 66.53 | 67.71 | 66.67 | 38.38 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，两项指标的行业排名分别为 11/71 ， 5/71。
[{"date":"2026-03-31","value":"32.08","vol":"297.05"},{"date":"2025-12-31","value":"58.87","vol":"39.85"},{"date":"2025-09-30","value":"33.04","vol":"45.81"},{"date":"2025-06-30","value":"-11.35","vol":"6902.14"},{"date":"2025-03-31","value":"-14.23","vol":"6125.11"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
32.08 | 58.87 | 33.04 | -11.35 | -14.23 |
| 行业(%) | 297.05 | 39.85 | 45.81 | 6902.14 | 6125.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"134.34","vol":"74.22"},{"date":"2025-12-31","value":"124.32","vol":"33.79"},{"date":"2025-09-30","value":"93.33","vol":"45.67"},{"date":"2025-06-30","value":"-8.97","vol":"5.21"},{"date":"2025-03-31","value":"-14.84","vol":"-8.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
134.34 | 124.32 | 93.33 | -8.97 | -14.84 |
| 行业(%) | 74.22 | 33.79 | 45.67 | 5.21 | -8.79 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 24/71 ， 19/71。
[{"date":"2026-03-31","value":"0.06","vol":"0.06"},{"date":"2025-12-31","value":"0.34","vol":"0.29"},{"date":"2025-09-30","value":"0.21","vol":"0.21"},{"date":"2025-06-30","value":"0.11","vol":"0.13"},{"date":"2025-03-31","value":"0.05","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.06 | 0.34 | 0.21 | 0.11 | 0.05 |
| 行业(次) | 0.06 | 0.29 | 0.21 | 0.13 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.27","vol":"0.29"},{"date":"2025-12-31","value":"1.71","vol":"1.29"},{"date":"2025-09-30","value":"0.88","vol":"0.90"},{"date":"2025-06-30","value":"0.56","vol":"0.55"},{"date":"2025-03-31","value":"0.24","vol":"0.25"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.27 | 1.71 | 0.88 | 0.56 | 0.24 |
| 行业(次) | 0.29 | 1.29 | 0.90 | 0.55 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"41.69","vol":"-78.67"},{"date":"2025-12-31","value":"26.76","vol":"12.85"},{"date":"2025-09-30","value":"39.72","vol":"0.21"},{"date":"2025-06-30","value":"6.84","vol":"-1377.65"},{"date":"2025-03-31","value":"-13.19","vol":"-2083.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 41.69 | 26.76 | 39.72 | 6.84 | -13.19 |
| 行业 | -78.67 | 12.85 | 0.21 | -1377.65 | -2083.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.79","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.62","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.79 | - | 0.62 | - |
| 行业 | 0.00 | 1.74 | 0.00 | 1.55 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 23/71 ， 16/71。
[{"date":"2026-03-31","value":"0.66","vol":"6.66"},{"date":"2025-12-31","value":"0.67","vol":"5.80"},{"date":"2025-09-30","value":"0.86","vol":"6.07"},{"date":"2025-06-30","value":"0.69","vol":"6.57"},{"date":"2025-03-31","value":"0.80","vol":"7.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.66 | 0.67 | 0.86 | 0.69 | 0.80 |
| 行业 | 6.66 | 5.80 | 6.07 | 6.57 | 7.73 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.42","vol":"5.14"},{"date":"2025-12-31","value":"0.45","vol":"4.43"},{"date":"2025-09-30","value":"0.44","vol":"4.89"},{"date":"2025-06-30","value":"0.25","vol":"5.24"},{"date":"2025-03-31","value":"0.32","vol":"6.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.42 | 0.45 | 0.44 | 0.25 | 0.32 |
| 行业 | 5.14 | 4.43 | 4.89 | 5.24 | 6.33 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 3/71 ， 12/71。
[{"date":"2026-03-31","value":"48.55","vol":"28.78"},{"date":"2025-12-31","value":"49.07","vol":"28.75"},{"date":"2025-09-30","value":"49.32","vol":"28.02"},{"date":"2025-06-30","value":"48.49","vol":"26.19"},{"date":"2025-03-31","value":"47.77","vol":"26.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
48.55 | 49.07 | 49.32 | 48.49 | 47.77 |
| 行业(%) | 28.78 | 28.75 | 28.02 | 26.19 | 26.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.95","vol":"2.54"},{"date":"2025-12-31","value":"0.98","vol":"1.42"},{"date":"2025-09-30","value":"1.01","vol":"0.58"},{"date":"2025-06-30","value":"0.98","vol":"1.11"},{"date":"2025-03-31","value":"0.95","vol":"0.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.95 | 0.98 | 1.01 | 0.98 | 0.95 |
| 行业(%) | 2.54 | 1.42 | 0.58 | 1.11 | 0.80 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.51","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.78","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.19","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]